Metabolic encephalopathy in alcoholic patients, how to find out?;Encéphalopathie métabolique chez l'alcoolique chronique, comment s'orienter ?

Reanimation

Volumn 18, Issue 7, 2009, Pages 590-597

  Jacobs, F ^a   Raynard, B ^b  

^a HÔPITAL ANTOINE BÉCLÈRE   (France)

^b INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Alcohol abuse; Complications; Encephalopathy; Ethanol

Indexed keywords

ALCOHOL WITHDRAWAL; ALCOHOLISM; CLINICAL FEATURE; HEPATIC ENCEPHALOPATHY; HUMAN; MARCHIAFAVA BIGNAMI DISEASE; METABOLIC ENCEPHALOPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; SHORT SURVEY; WERNICKE KORSAKOFF SYNDROME;

EID: 70349748319     PISSN: 16240693     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.reaurg.2009.07.001     Document Type: Short Survey

References (51)

1. Moss M., and Burnham E.L. Alcohol abuse in the critically ill patient. Lancet 368 (2006) 2231-2242
2. Brun-Buisson C., Meshaka P., Pinton P., Vallet B., and EPISEPSIS Study Group. EPISEPSIS: a reappraisal of the epidemiology and outcome of severe sepsis in French intensive care units. Intensive Care Med 30 (2004) 580-588
3. O'Brien Jr. J.M., Lu B., Ali N.A., Martin G.S., Aberegg S.K., Marsh C.B., et al. Alcohol dependence is independently associated with sepsis, septic shock, and hospital mortality among adult intensive care unit patients. Crit Care Med 35 (2007) 345-350
4. Gacouin A., Legay F., Camus C., Volatron A.C., Barbarot N., Donnio P.Y., et al. At-risk drinkers are at higher risk to acquire a bacterial infection during an intensive care unit stay than abstinent or moderate drinkers. Crit Care Med 36 (2008) 1735-1741
5. Kumari M., and Ticku M.K. Regulation of NMDA receptors by ethanol. Prog Drug Res 54 (2000) 153-189
6. Heinz A., Ragan P., Jones D.W., Hommer D., Williams W., et al. Reduced central serotonin transporters in alcoholism. Am J Psychiatry 155 (1998) 1544-1549
7. Lindholm S., Ploj K., Kranck J., and Nylander I. Repeated ethanol administration induces short- and long-term changes in enkephalin and dynorphin tissue concentration in rat brain. Alcohol 22 (2000) 165-171
8. De la Monte S.M. Disproportionate atrophy of cerebral white matter in chronic alcoholics. Arch Neurol 45 (1988) 990-992
9. Badsberg Jensen G., and Pakkenberg B. Do alcoholics drink their neurons away?. Lancet 342 (1993) 1201
10. Kril J.J., Halliday G.M., Svoboda M.D., and Cartwright H. The cerebral cortex is damaged in chronic alcoholics. Neuroscience 79 (1997) 983-998
11. Lewhol J.M., Dodd P.R., Mayfield R.D., and Harris R.A. Application of DNA microarrays to study human alcoholism. J Biomed Sci 8 (2001) 28-36
12. Harding A.J., Halliday G.M., Ng J.L.F., Harper C.G., and Kril J.J. Loss of vasopressin-immunoreactive neurons in alcoholics is dose-related and time-dependent. Neuroscience 72 (1996) 699-708
13. Baker K., Harding A., Halliday G., Kril J.J., and Harper C. Neuronal loss in functional zones of the cerebellum of chronic alcoholics with and without Wernicke's encephalopathy. Neuroscience 91 (1999) 429-438
14. Harper C., and Matsumoto I. Ethanol and brain damage. Curr Opin Pharmacol 5 (2005) 73-78
15. McMullen P.A., Saint-Cyr J.A., and Carlen P.L. Morphological alterations in rat CA1 hippocampal pyramidal cell dendrites resulting chronic ethanol consumption and withdrawal. J Comp Neurol 225 (1984) 111-118
16. Reinert D.F., and Allen J.P. The Alcohol Use Disorders Identification Test (AUDIT): a review of recent research. Alcohol Clin Exp Res 26 (2002) 272-279
17. Soderstrom C.A., Smith G.S., Kufera J.A., Dischinger P.C., Hebel J.R., McDuff D.R., et al. The accuracy of the CAGE, the Brief Michigan Alcoholism Screening Test, and the Alcohol Use Disorders Identification Test in screening trauma center patients for alcoholism. J Trauma 43 (1997) 962-969
18. National Institute of Alcohol Abuse and Alcoholism. Helping patients who drink too much: a clinician's guide. http://pubs.niaaa.nih.gov/publications.practitioner/cliniciansGuide2005/clinicians_guide.htm (site consulté en mai 2009).
19. Sanna E., Mostallino M.C., Busonero F., Talani G., Tranquilli S., Mameli M., et al. Changes in GABA(A) receptor gene expression associated with selective alterations in receptor function and pharmacology after ethanol withdrawal. J Neurosci 23 (2003) 11711-11724
20. Nutt D. Alcohol and the brain. Pharmacological insights for psychiatrists. Br J Psychiatry 175 (1999) 114-119
21. Lingford-Hughes A., and Nutt D. Neurobiology of addiction and implications for treatment. Br J Psychiatry 182 (2003) 97-100
22. Richardson J.D., Cocanour C.S., Kern J.A., Garrison R.N., Kirton O.C., Cofer J.B., et al. Perioperative risk assessment in elderly and high-risk patients. J Am Coll Surg 199 (2004) 133-146
23. Schwan R., Albuisson E., Malet L., Loiseaux M.N., Reynaud M., Schellenberg F., et al. The use of biological laboratory markers in the diagnosis of alcohol misuse: an evidence-based approach. Drug Alcohol Depend 74 (2004) 273-279
24. Fleming M., and Mundt M. Carbohydrate-deficient transferrin: validity of a new alcohol biomarker in a sample of patients with diabetes and hypertension. J Am Board Fam Pract 17 (2004) 247-255
25. Hannuksela M.L., Liisanantti M.K., Nissinen A.E., and Savolainen M.J. Biochemical markers of alcoholism. Clin Chem Lab Med 45 (2007) 953-961
26. Bleich S., Carl M., Bayerlein K., Reulbach U., Biermann T., Hillemacher T., et al. Evidence of increased homocysteine levels in alcoholism: the Franconian alcoholism research studies (FARS). Alcohol Clin Exp Res 29 (2005) 334-336
27. McKeon A., Frye M.A., and Delanty N. The alcohol withdrawal syndrome. J Neurol Neurosurg Psychiatry 79 (2008) 854-862
28. Castaigne P., Buge A., Cambier J., Escourolle R., and Rancurel G. La maladie de Marchiafava-Bignami : étude anatomoclinique de dix observations. Rev Neurol 3 (1971) 179-196
29. Charne M.E. Brain lesions in alcoholics. Alcohol Clin Exp Res 17 (1993) 2-11
30. Ménégon P., Sibon I., Pachai C., Orgogozo J.M., and Dousset V. Marchiafava-Bignami disease: diffusion-weighted MRI in corpus callosum and cortical lesions. Neurology 65 (2005) 475-477
31. Arbelaez A., Pajon A., and Castillo M. Acute Marchiafava-Bignami disease: MR findings in two patients. AJNR Am J Neuroradiol 24 (2003) 1955-1957
32. Manzo L., Locatelli C., Candura S.M., and Costa L.G. Nutrition and alcohol neurotoxicity. Neurotoxicology 15 (1994) 555-565
33. McCandless D.W., Schenker S., and Cook M. Encephalopathy of thiamine deficieny: studies of intracerebral mechanisms. J Clin Invest 47 (1968) 2268-2280
34. Hazell A.S., Todd K.G., and Butterworth R.F. Mechanisms of neuronal cell death in Wernicke's encephalopathy. Metab Brain Dis 13 (1998) 97-122
35. Chan H., Butterworth R.F., and Hazell A.S. Primary cultures of rat astrocytes respond to thiamine deficiency-induced swelling by downregulating aquaporin-4 levels. Neurosci Lett 366 (2004) 231-234
36. Harper C.G., Giles M., and Finlay-Jones R. Clinical signs in the Wernicke-Korsakoff complex: a retrospective analysis of 131 cases diagnosed at necropsy. J Neurol Neurosurg Psychiatry 49 (1986) 341-345
37. Jiang W., Gagliardi J.P., Raj Y.P., Silvertooth E.J., Christopher E.J., and Krishnan K.R. Acute psychotic disorder after gastric bypass surgery: differential diagnosis and treatment. Am J Psychiatry 163 (2006) 15-19
38. Kulkarni S., Lee A.G., Holstein S.A., and Warner J.E. You are what you eat. Surv Ophthalmol 50 (2005) 389-393
39. Ghez C. Vestibular paresis: a clinical feature of Wernicke's disease. Neurol Neurosurg Psychiatry 32 (1969) 134-139
40. Sechi G., and Serra A. Wernicke's encephalopathy: new clinical settings and recent advances in diagnosis and management. Lancet Neurol 6 (2007) 442-455
41. Caine D., Halliday G.M., Kril J.J., and Harper C.G. Operational criteria for the classification of chronic alcoholics: identification of Wernicke's encephalopathy. J Neurol Neurosurg Psychiatry 62 (1997) 51-60
42. Antunez E., Estruch R., Cardenal C., Nicolas J.M., Fernandez-Sola J., and Urbano-Marquez A. Usefulness of CT and MR imaging in the diagnosis of acute Wernicke's encephalopathy. AJR Am J Roentgenol 171 (1998) 1131-1137
43. Zuccoli G., Santa Cruz D., Bertolini M., Rovira A., Gallucci M., Carollo C., et al. MR imaging findings in 56 patients with Wernicke encephalopathy: nonalcoholics may differ from alcoholics. AJNR Am J Neuroradiol 30 (2009) 171-176
44. Serdaru M., Hausser-Hauw C., Laplane D., Buge A., Castaigne P., Goulon M., et al. The clinical spectrum of alcoholic pellagra encephalopathy. A retrospective analysis of 22 cases studied pathologically. Brain 111 (1988) 829-842
45. Ischii N., and Nishihara Y. Pellagra among chronic alcoholics: clinical and pathological study of 20 necrosy cases, Journal of Neurology. Neurosurgery and Psychiatry 44 (1981) 209-215
46. Dillon J.C., Malfait P.H., Demaux G., and Foldi-Hope C. Les métabolites urinaires de la niacine au cours de la pellagre. Ann Nutr Metab 36 (1992) 181-185
47. Ferenci P., Lockwood A., Mullen K., Tarter R., Weissenborn K., and Blei A.T. Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 35 (2002) 716-721
48. Francoz C., and Durand F. Encéphalopathie hépatique : comment optimiser la prise en charge en réanimation ?. Reanimation 16 (2007) 498-503
49. Nicolao F., Efrati C., Masini A., Merli M., Attili A.F., and Riggio O. Role of determination of partial pressure of ammonia in cirrhotic patients with and without hepatic encephalopathy. J Hepatol 38 (2003) 441-446
50. Amodio P., Marchetti P., Del Piccolo F., de Tourtchaninoff M., Varghese P., Zuliani C., et al. Spectral versus visual EEG analysis in mild hepatic encephalopathy. Clin Neurophysiol 110 (1999) 1334-1344
51. Rovira A., Alonso J., and Cordoba J. MR imaging findings in hepatic encephalopathy. AJNR Am J Neuroradiol 29 (2008) 1612-1621